In the news: FTZ speculation, regulatory disputes and life sciences challenges

Shanghai's Free Trade Zone remains the focus of speculation, while a solution has been proposed for the standoff between US and Chinese regulators. Life sciences companies are having an increasingly tough time protecting their IP in China.

5 minute read September 26, 2013 at 12:35 PM

clpstaff and clp articles

Shanghai FTZ – speculation continues

This week the South China Morning Post reported that internet users in the Shanghai Free Trade Zone would be able to access websites blocked in the rest of China, such as Facebook and Twitter.

Exclusive Content

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

Access to 3000+ essential documents, including key PRC laws translated into English
Newsletters with business-critical and sector-specific updates
Premium mobile access with timely analysis on China’s fast-changing market

Already a Subscriber? Log In Here

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)